http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102863474-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_22aeda08e1c99ac9d05c1009c6c9a84c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-0093
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-0006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-00
filingDate 2011-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3344cb0fbe2421cda6b5d2218837c53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a73ca1737565d07d2822a5622a9d08e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e8f56bcbc5dce47eb1684cca2221749
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e443734e033d91d2364878617c1aeaf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_037229995e2f3da8e5b8a1fa8f59f519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_412ff562be5cf6fc2e2ce06a0af6c2b8
publicationDate 2013-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102863474-A
titleOfInvention A kind of platinum compound for treating cell proliferative diseases, its preparation method and application
abstract The invention discloses a class of platinum compounds whose leaving groups contain malonic acid derivatives containing amino groups and alkylamino groups, their pharmaceutically acceptable salts, their preparation methods and pharmaceutical compositions containing the above compounds. The invention also discloses the use of the above compounds in the treatment of cell proliferation diseases, especially in the treatment of cancer. The platinum compound of the invention has high solubility in water and low toxic and side effects.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9725477-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014114183-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104768962-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014075391-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104995201-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104768962-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020043144-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104995201-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11661434-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112533935-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112533935-A
priorityDate 2011-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468333729
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468333552
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466478604
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466359521
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419594677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466069051
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468327650

Total number of triples: 44.